On June 6, 2017, Knowledge Ecology International wrote to the U.S. Department of Health and Human Services (DHHS) asking the Department to adopt a policy on the licensing of federally-funded CRISPR patented inventions. (Copy here).
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On June 5, 2017, KEI provided comments to the NIH/NCI, on a prospective grant of an exclusive license to PathoVax, relating to HPV vaccines. On July 10,… Continue Reading
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) This was our comment on the license. See below for the June 8, 2017 NIH response, rejecting our requests for changes to the license to address pricing… Continue Reading
(More on government funded inventions here. Other KEI comments on NIH licenses are found here.) On May 31, 2017, we sent the following comment to the NIH regarding the proposed exclusive license on certain patents for cancer treatment to GeneXion Oncology. May 31,… Continue Reading
For additional information, contact:
The final text of the resolution (WHA70.12, Cancer prevention and control in the context of an integrated approach) can be found it here: http://apps.who.int/gb/ebwha/pdf_files/WHA70/A70_R12-en.pdf
On Tuesday, 30 May 2017, Knowledge Ecology International delivered the following intervention on Preparation for the third High-Level Meeting of the General Assembly on the Prevention and Control of Noncommunicable Diseases, to be held in 2018. The statement was delivered by Thiru Balasubramaniam.
On Monday, 29 May 2017, Knowledge Ecology International delivered the following intervention on the Global vaccine action plan. The statement was delivered by James Love.
WHA70: Statement of Knowledge Ecology International on antimicrobial resistance
On Wednesday, 24 May 2017, Knowledge Ecology International delivered the following intervention on antimicrobial resistance. This statement was read by Andrew Goldman.
KEI would like to call attention to a proposal introduced in the United States Congress, as Senate Bill 771, sponsored by 16 US Senators, and HR 1776, which has 14 sponsors in the House of Representatives.SEC. 409K of the bill is titled, “PRIZE FUND FOR NEW AND MORE EFFECTIVE TREATMENTS OF BACTERIAL INFECTIONS.”
SCCR 32: IFLA on Orphan Works
>> IFLA: Thank you again Mr. Chair for allowing IFLA to take the floor. IFLA supports initiatives to support and make available cumulative knowledge and cultural heritage and recognize the role of libraries and archives in that respect. We further… Continue Reading
KEI Comments for 70th World Health Assembly Listening Session at DHHS
Today KEI attended the annual listening session at DHHS, when speakers are alotted no more than 1.5 minutes to speak on a specific agenda item, with no more than two agenda items per speaker. Our brief comments were focused on advancing the delinkage approach in the contexts of the GSPOA, CEWG, and cancer.